Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application.
about
A spinal cord window chamber model for in vivo longitudinal multimodal optical and acoustic imaging in a murine model.Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.P45 forms a complex with FADD and promotes neuronal cell survival following spinal cord injury.PMA and ionomycin induce glioblastoma cell death: activation-induced cell-death-like phenomena occur in glioma cellsGenetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injuryThe change tendency of PI3K/Akt pathway after spinal cord injury.Role of MK2 signaling pathway in the chronic compression of cervical spinal cordA brief analysis of traditional chinese medical elongated needle therapy on acute spinal cord injury and its mechanism.Epothilone B impairs functional recovery after spinal cord injury by increasing secretion of macrophage colony-stimulating factor.Protease activated receptor 2 controls myelin development, resiliency and repair.Cell therapy for spinal cord injury with olfactory ensheathing glia cells (OECs).Demyelination initiated by oligodendrocyte apoptosis through enhancing endoplasmic reticulum-mitochondria interactions and Id2 expression after compressed spinal cord injury in rats.Carvedilol promotes neurological function, reduces bone loss and attenuates cell damage after acute spinal cord injury in rats.Role of Caspase-8 and Fas in Cell Death After Spinal Cord Injury.Thymoquinone reduces spinal cord injury by inhibiting inflammatory response, oxidative stress and apoptosis via PPAR-γ and PI3K/Akt pathways.Apolipoprotein E Deficiency Exacerbates Spinal Cord Injury in Mice: Inflammatory Response and Oxidative Stress Mediated by NF-κB Signaling Pathway.
P2860
Q27335680-E17F39E6-DE1D-4DB2-873C-5F28D6473907Q33898347-3CE2A926-F6B2-46BE-9DF8-AD53A56B2131Q34919673-3CA110E6-7BAA-4E58-ABDE-7B8FBABAA5A8Q35018554-8A1D207D-4499-4C67-9740-6B53F2CF011BQ36359579-5A63AC4D-E093-4059-B8ED-F7C04937B181Q36420219-F0EDD699-0319-4C27-9418-386602758218Q36420265-8CC66A46-A90A-4984-AEAB-C3329E69A0E5Q42826122-AFA18CAE-7C58-485E-89C9-D3EA65786DE3Q47388453-8C4F931B-BE43-4298-9694-F43F36060DD8Q47663969-A177636B-F9E1-4060-B26A-A2A8058B1A8CQ47734306-113FF424-C92A-4ECB-A5B0-76D77CBA98FCQ47796994-5803E220-9D2F-4F48-A419-1B1C6CA1620AQ51032708-DF4EE2D1-5074-4524-A163-09D78ADD8164Q52581900-DC500D60-8988-46C5-81E9-C548F48BEDF7Q55112804-DFCB321D-8639-442C-A0AE-B74713C5CAFDQ55280839-28465B20-6735-491A-9D5D-2F55B47E1E25
P2860
Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Fas/FasL-mediated apoptosis an ...... ational, clinical application.
@ast
Fas/FasL-mediated apoptosis an ...... ational, clinical application.
@en
type
label
Fas/FasL-mediated apoptosis an ...... ational, clinical application.
@ast
Fas/FasL-mediated apoptosis an ...... ational, clinical application.
@en
prefLabel
Fas/FasL-mediated apoptosis an ...... ational, clinical application.
@ast
Fas/FasL-mediated apoptosis an ...... ational, clinical application.
@en
P2860
P1476
Fas/FasL-mediated apoptosis an ...... ational, clinical application.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00401-011-0882-3
P577
2011-10-29T00:00:00Z